A

Arecor Therapeutics PLC
LSE:AREC

Watchlist Manager
Arecor Therapeutics PLC
LSE:AREC
Watchlist
Price: 80.5 GBX 1.9% Market Closed
Market Cap: 30.4m GBX

Arecor Therapeutics PLC
Tax Provision

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Arecor Therapeutics PLC
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
A
Arecor Therapeutics PLC
LSE:AREC
Tax Provision
ÂŁ382k
CAGR 3-Years
-21%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Tax Provision
-$2.8m
CAGR 3-Years
-196%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Tax Provision
$2.2m
CAGR 3-Years
6%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Tax Provision
ÂŁ1.9m
CAGR 3-Years
-42%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Tax Provision
-ÂŁ9.2m
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
6%
Oxford BioMedica PLC
LSE:OXB
Tax Provision
-ÂŁ1.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Arecor Therapeutics PLC
Glance View

Market Cap
30.4m GBX
Industry
Biotechnology

Arecor Therapeutics Plc is a biopharmaceutical company that targets improving patient care by bringing medicines to market through the enhancement of existing therapeutic products. The firm targets improving patient care by bringing medicines to market through the existing therapeutic products. The company partners with global pharmaceutical and biotechnology companies to apply the Arestat technology to their products under a technology licensing model. These products can be at any stage in development from early phase clinical development through to products that are already on the market. The areas of applications of the technology are biologicals, biosimilars, therapeutic vaccines and therapeutic peptides.

AREC Intrinsic Value
20.08 GBX
Overvaluation 75%
Intrinsic Value
Price
A

See Also

What is Arecor Therapeutics PLC's Tax Provision?
Tax Provision
382k GBP

Based on the financial report for Dec 31, 2024, Arecor Therapeutics PLC's Tax Provision amounts to 382k GBP.

What is Arecor Therapeutics PLC's Tax Provision growth rate?
Tax Provision CAGR 5Y
5%

Over the last year, the Tax Provision growth was 10%. The average annual Tax Provision growth rates for Arecor Therapeutics PLC have been -21% over the past three years , 5% over the past five years .

Back to Top